- Home
- PEBO vs VIR Comparison
PEBO vs VIR Comparison
Compare PEBO & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PEBO | VIR |
|---|---|---|
| Founded | 1902 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.5B |
| IPO Year | 2005 | 2019 |
Fundamental Metrics
Financial Performance| Metric | PEBO | VIR |
|---|---|---|
| Price | $38.53 | $10.03 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 7 |
| Target Price | ★ $37.33 | $19.43 |
| AVG Volume (30 Days) | 185.6K | ★ 2.1M |
| Earning Date | 04-21-2026 | 05-06-2026 |
| Dividend Yield | ★ 4.94% | N/A |
| EPS Growth | N/A | ★ 17.49 |
| EPS | ★ 0.81 | N/A |
| Revenue | $197,000.00 | ★ $68,556,000.00 |
| Revenue This Year | $17.29 | $270.22 |
| Revenue Next Year | $2.97 | N/A |
| P/E Ratio | $46.72 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $27.49 | $4.16 |
| 52 Week High | $37.97 | $11.66 |
Technical Indicators
Market Signals| Indicator | PEBO | VIR |
|---|---|---|
| Relative Strength Index (RSI) | 67.65 | 60.72 |
| Support Level | $33.72 | $8.40 |
| Resistance Level | N/A | $10.10 |
| Average True Range (ATR) | 0.65 | 0.49 |
| MACD | 0.17 | 0.17 |
| Stochastic Oscillator | 83.05 | 79.78 |
Price Performance
Historical ComparisonAbout PEBO Peoples Bancorp Inc.
Peoples Bancorp Inc (Marietta OH) is a financial holding company. As a community bank, it offers a complete line of banking, insurance, investment, and trust solutions through its financial subsidiaries. It offers demand deposit accounts, savings accounts, real estate mortgage loans, merchant credit card transaction processing services, corporate and personal trust services, life, health, property, and casualty insurance products, and brokerage services. The bank also offers telephone and internet-based banking through both personal computers and mobile devices.
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.